The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer

نویسندگان

  • Dimple Chakravarty
  • Andrea Sboner
  • Sujit S. Nair
  • Eugenia Giannopoulou
  • Ruohan Li
  • Sven Hennig
  • Juan Miguel Mosquera
  • Jonathan Pauwels
  • Kyung Park
  • Myriam Kossai
  • Theresa Y. MacDonald
  • Jacqueline Fontugne
  • Nicholas Erho
  • Ismael A. Vergara
  • Mercedeh Ghadessi
  • Elai Davicioni
  • Robert B. Jenkins
  • Nallasivam Palanisamy
  • Zhengming Chen
  • Shinichi Nakagawa
  • Tetsuro Hirose
  • Neil H. Bander
  • Himisha Beltran
  • Archa H. Fox
  • Olivier Elemento
  • Mark A. Rubin
چکیده

The androgen receptor (AR) plays a central role in establishing an oncogenic cascade that drives prostate cancer progression. Some prostate cancers escape androgen dependence and are often associated with an aggressive phenotype. The oestrogen receptor alpha (ERα) is expressed in prostate cancers, independent of AR status. However, the role of ERα remains elusive. Using a combination of chromatin immunoprecipitation (ChIP) and RNA-sequencing data, we identified an ERα-specific non-coding transcriptome signature. Among putatively ERα-regulated intergenic long non-coding RNAs (lncRNAs), we identified nuclear enriched abundant transcript 1 (NEAT1) as the most significantly overexpressed lncRNA in prostate cancer. Analysis of two large clinical cohorts also revealed that NEAT1 expression is associated with prostate cancer progression. Prostate cancer cells expressing high levels of NEAT1 were recalcitrant to androgen or AR antagonists. Finally, we provide evidence that NEAT1 drives oncogenic growth by altering the epigenetic landscape of target gene promoters to favour transcription.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Therapeutic Efficacy Analysis of lncRNA NEAT1 Gene Knockout and Apoptosis Induction in Prostate Cancer Cell Line Using CRISPR/Cas9

Background and Objective: Long non-coding ribonucleic acid (lncRNA) has been identified as an important gene regulator and prognostic marker in various cancers. The present study aimed to investigate the effects of Nuclear Paraspeckle Assembly Transcript1 (NEAT1) gene knockout using Clustered Regularly Interspaced Short Palindromic Repeats-associated Protein 9 (CRISPR/Cas9) in PC-3 cell line. ...

متن کامل

lncRNA NEAT1 is closely related with progression of breast cancer via promoting proliferation and EMT.

OBJECTIVE Breast cancer (BC) is one of the most common cancers in females. Abnormal proliferation and metastasis are key reasons that cause mortality in BC patients. More and more evidence showed that lncRNA played an important role in the BC development, but the mechanism was not well established. PATIENTS AND METHODS The expression of lncRNA NEAT1 was detected in 40 BC patients by qRT-PCR t...

متن کامل

The Roles of Long non-coding RNAs (lncRNA) in Prostate Cancer

Background & Objective: Prostate cancer is a compound condition in which gene expression has altered. Several surveys have revealed that genetic components have been involved in prostate cancer progression. Findings proposed that they can modify a noteworthy portion of disposing of elements, which is associated to the developing prostate cancer in protein coding sequences. The purpose of this r...

متن کامل

Clinical significance of up-regulated lncRNA NEAT1 in prognosis of ovarian cancer.

OBJECTIVE The purpose of the present study was to examine the expression levels of lncRNA NEAT1 in fresh ovarian cancer (OC) tissue and matched adjacent normal tissue specimens, and investigate the clinical significance of NEAT1 in OC. PATIENTS AND METHODS NEAT1 levels in OC tissues and matched adjacent normal tissue specimens were tested by qRT-PCR. Then, statistical analysis was performed t...

متن کامل

The clinical value of lncRNA NEAT1 in digestive system malignancies: A comprehensive investigation based on 57 microarray and RNA-seq datasets

This comprehensive investigation was performed to evaluate the expression level and potential clinical value of NEAT1 in digestive system malignancies. A total of 57 lncRNA datasets of microarray or RNA-seq and 5 publications were included. The pooled standard mean deviation (SMD) indicated that NEAT1 was down-regulated in esophageal carcinoma (ESCA, SMD = -0.35, 95% CI: -0.5~-0.20, P < 0.0001)...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 5  شماره 

صفحات  -

تاریخ انتشار 2014